Vertex Pharmaceuticals VRTX Income Tax
Income Tax at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Vertex Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The official record: Vertex Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vertex Pharmaceuticals's income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Vertex Pharmaceuticals's income tax?
- Vertex Pharmaceuticals (VRTX) reported income tax of $221.5M in Q1 2026.
- How has Vertex Pharmaceuticals's income tax changed year-over-year?
- Vertex Pharmaceuticals's income tax increased by 163.4% year-over-year, from $84.1M to $221.5M.
- What is the long-term trend for Vertex Pharmaceuticals's income tax?
- Over 4 years (2021 to 2025), Vertex Pharmaceuticals's income tax has grown at a 15.5% compound annual growth rate (CAGR), from $388.3M to $690M.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.